SGLT2 inhibitors and outcomes in the chronic Post-LVAD phase: a multicenter real-world cohort study

More on SGLT2 inhibitors

• SGLT2 inhibitors raise genital but not urinary infection risk

  Clinical Pharmacology and Therapeutics · 4 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• Proteomic multi-organ aging accelerates before adverse events in heart failure patients

  European Journal of Heart Failure · 2 Oct 2026

  

• Calf size and physical function predict heart failure mortality

  Archives of Gerontology and Geriatrics · 4 Oct 2026